Why this matters: Short interest in the Defiance Quantum ETF QTUM nearly doubled in a single week. That repositioning has drained the lending pool fast — and options traders are taking notice.
Three distinct signals aligned over 48 hours.
Short interest jumped 94% week-on-week to 1.92% of free float. That move — from roughly 271,000 shares short on June 12 to 526,000 by June 22 — is the sharpest one-week build in the 30-day history captured here.
Simultaneously, borrow availability collapsed. Availability sat above 190% as recently as June 8. It has since fallen to 23.5% — meaning only one share is currently available to borrow for every four already lent out. That is well inside "tight" territory. The 52-week low sits at 12.8%.
The cost to borrow has climbed with it. CTB rose 42% over the past week to 1.10%, up from around 0.75% in mid-June. That remains modest in absolute terms, but the trajectory is steep.
Options positioning shifted at the same time. The put-call ratio stands at 0.73, nearly 1.9 standard deviations above its 20-day mean of 0.64. Puts have been elevated for two consecutive sessions. The PCR 52-week range runs from 0.30 to 1.38, so current levels are not extreme — but the direction is consistent with the borrow-market pressure.
The ORTEX short score has climbed steadily from 43.95 on June 9 to 47.77 on June 22. That is not yet a high reading, but the 10-session drift higher mirrors the borrow tightening exactly.
QTUM itself fell 3.1% on June 23 after a 0.7% weekly gain. The ETF is up 6.5% over the past month, which may have prompted some investors to hedge exposure or initiate shorts against recent gains.
The price is $163.34. There are no upcoming earnings events for this ETF, so the current activity is flow-driven rather than event-driven.
Watch: Whether availability continues to tighten toward the 52-week low of 12.8% — and whether the cost to borrow accelerates as a result.
See the live data behind this article on ORTEX.
Open QTUM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
